Guidance
Tetanus serosurvey guidance
This annex provides guidance on the use of serosurveys to estimate population immunity and monitor disease risk for tetanus. The aims of tetanus vaccination are 1) to achieve and sustain maternal and neonatal tetanus elimination (MNTE) and 2) to ensure lifelong tetanus protection in all people by achieving high coverage with six doses of tetanus vaccine (three primary plus three booster doses) through routine immunization.
Authors
Languages
- English
Publication year
2018
Publisher
WHO
Type
Guidance
Categories
- Programme management
Diseases
- Tetanus
Organisations
- World Health Organisation (WHO)
Topic references
EPI-CORE-TETANUS
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Protecting All Against Tetanus: Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations | World Health Organization (WHO) | 2019 | Guidance | French |
| Replacement of TT with Td vaccine – July 2018 | UNICEF, World Health Organization (WHO) | 2018 | Guidance | French |
| Tetanus serosurvey guidance | World Health Organization (WHO) | 2018 | Guidance | English |
| Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts | Heather M. Scobie, S. Desai, Thomas Cherian, Tracey Goodman | 2020 | Journal article | English |
| Validation of Maternal and Neonatal Tetanus Elimination including a guide to the use of Lot Quality Assurance – Cluster Sample Surveys to assess neonatal tetanus mortality | World Health Organization (WHO) | 2014 | Guidance | English, French |
